Resona Asset Management Co. Ltd. Sells 4,105 Shares of Humana Inc. $HUM

Resona Asset Management Co. Ltd. lowered its position in shares of Humana Inc. (NYSE:HUM) by 9.2% during the third quarter, HoldingsChannel reports. The fund owned 40,683 shares of the insurance provider’s stock after selling 4,105 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in Humana were worth $10,553,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. UniSuper Management Pty Ltd grew its holdings in shares of Humana by 19.7% during the third quarter. UniSuper Management Pty Ltd now owns 14,575 shares of the insurance provider’s stock worth $3,792,000 after purchasing an additional 2,398 shares during the last quarter. Teacher Retirement System of Texas grew its holdings in Humana by 12.5% during the 3rd quarter. Teacher Retirement System of Texas now owns 63,332 shares of the insurance provider’s stock worth $16,477,000 after acquiring an additional 7,046 shares during the last quarter. Ridgewood Investments LLC increased its position in Humana by 21.3% in the 3rd quarter. Ridgewood Investments LLC now owns 1,140 shares of the insurance provider’s stock valued at $297,000 after acquiring an additional 200 shares during the period. Covestor Ltd raised its stake in shares of Humana by 46.0% during the third quarter. Covestor Ltd now owns 663 shares of the insurance provider’s stock valued at $173,000 after acquiring an additional 209 shares during the last quarter. Finally, CVA Family Office LLC lifted its holdings in shares of Humana by 92.7% during the third quarter. CVA Family Office LLC now owns 422 shares of the insurance provider’s stock worth $110,000 after purchasing an additional 203 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Humana Price Performance

Shares of HUM opened at $263.23 on Tuesday. The firm has a market cap of $31.66 billion, a PE ratio of 24.67, a price-to-earnings-growth ratio of 2.19 and a beta of 0.45. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $315.35. The business’s 50 day moving average price is $258.84 and its two-hundred day moving average price is $265.08. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to the consensus estimate of $31.99 billion. Humana had a net margin of 1.02% and a return on equity of 12.86%. The company’s quarterly revenue was up 11.1% on a year-over-year basis. During the same quarter last year, the firm posted $4.16 EPS. On average, equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Analyst Ratings Changes

HUM has been the subject of a number of recent research reports. Wolfe Research increased their price objective on Humana from $300.00 to $325.00 and gave the company an “outperform” rating in a report on Thursday, January 8th. Jefferies Financial Group raised Humana from a “hold” rating to a “buy” rating and increased their price target for the company from $253.00 to $313.00 in a research note on Friday, December 5th. Truist Financial cut their price objective on Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a research note on Monday, November 10th. Robert W. Baird decreased their target price on shares of Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research report on Thursday, December 11th. Finally, Wells Fargo & Company downgraded shares of Humana from an “overweight” rating to a “cautious” rating in a research report on Wednesday, January 7th. Eight equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and five have given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $293.37.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.